Tetra Bio-Pharma Provides Update on Its REDUVO(TM) New Drug Submission

Stock Information for Tetra Bio-Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Voluntary Bankruptcy
Tetra Bio-Pharma Cancels New Drug Submission to Health Canada
Tetra Bio-Pharma Announces Health Canada Authorization to Proceed with its Oral ARDS-003 New Drug in Human Trial
Tetra Bio-Pharma Announces Cease Trade Order
Tetra Bio-Pharma Announces Listing to OTCPink Market
REDUVO(TM) Marketing Approval on the Right Path
Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir
Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.